Поиск

SYSTEMIC REVIEW AND META-ANALYSIS OF LOCAL SALVAGE THERAPY AFTER EBRT FOR PROSTATE CANCER (MASTER STUDY)

The management of locally recurrent prostate cancer after radical radiotherapy remains controversial due to the perceived high incidence of severe genitourinary (GU) and gastrointestinal (GI) toxicity associated with any method of salvage radiotherapy. ...

SMAS LIFTING ULTRAFORMER

New technologies for ultrasonic lifting are available at the K+31 clinic on Lobachevskogo - Ultraformer III. Now, visitors to the department of aesthetic medicine have the opportunity to carry out even more effective contouring, leveling the relief, ...

RADIATION THERAPY: WORLD PROBLEMS ACCORDING TO THE IAEA

IAEA studies have found significant shortcomings in the provision of radiotherapy care - the treatment of cancer in children. The results showed that the existing gaps are global in scope. The study also identified ways to improve clinical practice. ...

MICROBIOTA RESEARCH AND PROBIOTIC MANUFACTURING AT K+31

Over 700 species of bacteria live on the mucous membranes in the oral cavity. There are several hundred species on the skin, and up to 1000 in the gastrointestinal tract. But not all bacteria are created equal. For example, E. coli, which has various ...

PARKINSON'S DISEASE: CAUSES AND TREATMENT. LIVE WITH NODEL MARINA ROMANOVNA

April 12, in honor of the day of the fight against Parkinson's disease, professor of the department of nervous diseases and neurosurgery, PMSMU named after I.M. Sechenov, doctor of medical sciences, consultant of the K+31 clinic, neurologist of the highest ...

ALLERGY MEDICATIONS TO REDUCE CANCER RISK?

The researchers concluded that the use of antihistamines may reduce the risk of developing hepatocellular carcinoma in patients with viral hepatitis B and C, but further research is needed. The use of H1 antihistamines (diphenhydramine, chloropyramine, ...

NEW POSSIBILITIES FOR THE TREATMENT OF ONCOPATHOLOGIES

Sotorasib has been shown to be effective in the treatment of colorectal cancer and pancreatic cancer with the KRAS G12C mutation in early clinical trials. The KRAS mutation is one of the most common in colorectal and pancreatic cancers. However, despite ...

Экстренная помощь